Dec 28, 2022

Featuring perspectives from Drs Alexey Danilov, Matthew Davids, Lindsey Roeker, Philip Thompson and Prof Dr Arnon Kater, including the following topics:

• Front-Line Treatment of Chronic Lymphocytic Leukemia (CLL)  
  • Introduction (0:00)
  • Cases: A man in his early 90s with Rai Stage 0 CLL who underwent surveillance x 5...

Dec 22, 2022

Featuring perspectives from Drs Erika Hamilton, Sara Hurvitz, Ian Krop, Shanu Modi and Sara Tolaney, including the following topics:

• Optimizing the Management of Localized HER2-Positive Breast Cancer
  • Introduction (0:00)
  • Case: A woman in her mid 60s with pulmonary hypertension and triple-positive, node-positive...

Dec 21, 2022

Featuring a slide presentation and related discussion from Dr Thomas Herzog, including the following topics:

• Keys to evaluating genetics in patients with ovarian cancer (0:00)
• Clinical trials evaluating PARP inhibitor maintenance therapy for patients with newly diagnosed ovarian cancer responding to platinum-based...

Dec 21, 2022

Featuring perspectives from Dr Thomas Herzog, including the following topics:

• Impact of PARP inhibitors (PARPi) on the care of patients with ovarian cancer (0:00)
• Clarifying the recent withdrawal of PARPi for treatment of recurrent or refractory ovarian cancer (4:13)
• Sequential use of PARPi for patients with advanced...

Dec 16, 2022

Emerging Role of Antibody‑Drug Conjugates in the Management of Non‑Small Cell Lung Cancer — Faculty Presentation 2: TROP2 and Other Investigational Targets for ADCs in Advanced NSCLC — Dr Alexander Spira

CME information and select publications